CN112877377A - Preparation method of high-purity diglyceride phosphate - Google Patents

Preparation method of high-purity diglyceride phosphate Download PDF

Info

Publication number
CN112877377A
CN112877377A CN202110053622.0A CN202110053622A CN112877377A CN 112877377 A CN112877377 A CN 112877377A CN 202110053622 A CN202110053622 A CN 202110053622A CN 112877377 A CN112877377 A CN 112877377A
Authority
CN
China
Prior art keywords
lysophospholipid
pfgdpd
acid
chelating agent
phosphate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202110053622.0A
Other languages
Chinese (zh)
Other versions
CN112877377B (en
Inventor
王方华
王永华
闵雪珂
杨博
王卫飞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
South China University of Technology SCUT
Original Assignee
South China University of Technology SCUT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by South China University of Technology SCUT filed Critical South China University of Technology SCUT
Priority to CN202110053622.0A priority Critical patent/CN112877377B/en
Publication of CN112877377A publication Critical patent/CN112877377A/en
Application granted granted Critical
Publication of CN112877377B publication Critical patent/CN112877377B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/64Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436Fatty acid esters
    • C12P7/6445Glycerides
    • C12P7/6481Phosphoglycerides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention belongs to the technical field of enzyme genetic engineering, and discloses a preparation method of high-purity diglyceride phosphate, which takes lysophospholipid as a raw material and pfGDPD treated by a metal ion chelating agent as a catalyst to hydrolyze the lysophospholipid in a water phase system to obtain a diglyceride phosphate product; the amino acid sequence of the pfGDPD is SEQID No: 1. The invention starts from lysophospholipid, can prepare high-purity diglyceride phosphate (such as GPC, GPE, GPI and the like) by one-step single enzymatic hydrolysis, and has the conversion rate close to 100 percent. The invention provides a new idea and method for the production of diglyceride phosphate.

Description

Preparation method of high-purity diglyceride phosphate
Technical Field
The invention belongs to the technical field of enzyme genetic engineering, and particularly relates to a method for obtaining a high-purity catalytic product of diglyceride phosphate by using an enzyme method.
Background
Diglyceride phosphate is a water-soluble small molecular substance normally existing in human body. Glycerol Phosphatidylcholine (GPC), Glycerol Phosphatidylethanolamine (GPE), Glycerol Phosphatidylinositol (GPI), and the like are common. Diacylglycerol phosphate is a product of phospholipid metabolism and plays an important physiological role in the human body. In the case of GPC, the most important physiological function of GPC in vivo is to cross the blood brain barrier, providing the necessary source of choline for the synthesis of acetylcholine and Phospholipids (PC). Clinical research shows that GPC has obvious curative effect on cerebral ischemic stroke, Alzheimer's disease and multiple cerebral infarction type dementia. The traditional Chinese medicine composition is clinically used for improving the liver protection effect of toxic liver injury and the like; meanwhile, GPC also has various obvious effects of preventing aging, reducing blood fat, strengthening brain and the like, and is increasingly emphasized as research and application of health products and pharmaceutical preparations, and the development of a preparation method of high-purity diglyceride phosphate has important value.
At present, the preparation method of the diglyceride of glycerophosphate mainly comprises 3 methods, namely a biological tissue direct extraction method, and the method has the advantages of complex process, low yield and high cost; secondly, the lecithin is prepared by hydrolysis, the method has simple process and low cost, but the post-treatment is quite complicated, the product purity is low, and particularly the problem of environmental protection cannot be solved. And thirdly, chemical synthesis, namely, preparation from basic chemical raw materials, but the steps are various, the process is complex, and the yield is low. The production of glycerophosphorylcholine from D-mannitol by a series of reactions was only 38.6% (based on D-mannitol) as an example. Therefore, it is urgently needed to develop a new preparation method, improve the product purity, reduce the production cost and simplify the production procedure, thereby promoting the wide application of the diglyceride phosphate.
Glycerol phosphodiesterase (GDPD; EC 3.1.4.46) is a class of enzymes that catalyzes the hydrolysis of the 3 '-5' phosphodiester bond of glycerol phosphodiesters. The inventors succeeded in constructing recombinant strains of Escherichia coli having a diacylglycerol Phosphodiesterase (pfGDPD) derived from Pyrococcus furiosus (Pyrococcus furiosus) and a method for producing an enzyme protein, which is capable of hydrolyzing a lysophospholipid substrate in addition to a diacylglycerol phosphate substrate, in previous studies (Wang FH, Lai LH, Liu YH, Yang B, Wang YH. Expression and Characterization of the characteristics of a Novel Glycerophosphodiester phosphor from Pyrococcus furiosus DSM 3638 at potas lysophosphoipase D activity.int.J.mol.Sci.2016,17(6), 831.). However, in the case of an experiment for hydrolyzing a lysophospholipid substrate, two products, i.e., a diglyceride phosphate (e.g., GPC, GPE, GPI, etc.) and a lysophosphatidic acid (LPA), are produced, and the use thereof for the preparation of a high-purity diglyceride phosphate is still not ideal.
Disclosure of Invention
Based on the fact that pfGDPD found by experiments has the characteristic of ester bond hydrolysis, the invention provides a brand-new preparation method of the diglyceride phosphate, starting from lysophospholipid, the high-purity diglyceride phosphate (such as GPC, GPE, GPI and the like) can be prepared by one-step single enzymatic hydrolysis, and the conversion rate is close to 100%.
The technical scheme of the invention is as follows:
a method for preparing high-purity diglyceride phosphate comprises hydrolyzing lysophospholipid in water phase system with lysophospholipid as raw material and metal ion chelating agent treated phosphodiesterase (pfGDPD) from Pyrococcus furiosus as enzyme catalyst to obtain diglyceride phosphate product; wherein the amino acid sequence of the pfGDPD is SEQID No. 1, and the nucleic acid sequence thereof is SEQID No. 2. Dissolving lysophospholipid substrate in buffer solution with pH8.0, adding pfGDPD treated by metal ion chelating agent into reaction system at 30-90 deg.C, and performing enzymolysis reaction to obtain high-purity diglyceride.
Preferably, the buffer solution is a boric acid buffer.
Preferably, the lysophospholipid is any one or more than two of Lysophosphatidylcholine (LPC), Lysophosphatidylethanolamine (LPE), Lysophosphatidylserine (LPS), Lysophosphatidylinositol (LPI), and Lysophosphatidylglycerol (LPG).
Preferably, the temperature of the treatment of the metal ion chelating agent is 4-90 ℃, the treatment time is 1-12h, and the concentration of the chelating agent is 10-50 mM.
Preferably, the chelating agent is one or more of ethylenediaminetetraacetic acid (EDTA), disodium ethylenediaminetetraacetate (EDTA-2Na), nitrilotriacetic acid (NTA), diethylenetriaminepentaacetic acid (DPTA) and salts thereof, Citric Acid (CA) and salts thereof, Tartaric Acid (TA) and salts thereof, and Gluconic Acid (GA) and salts thereof.
Preferably, the conditions of the enzymolysis reaction are that the temperature is 30-50 ℃, the time is 4-48 h, and the stirring is carried out at 300 +/-200 r/min.
Compared with the prior art, the invention has the following beneficial effects:
the invention uses the diglyceride phosphodiesterase (pfGDPD) from Pyrococcus furiosus treated by a metal ion chelating agent as an enzyme catalyst, and can prepare high-purity diglyceride phosphate (such as GPC, GPE, GPI and the like) by single enzymatic hydrolysis from lysophospholipid, does not contain impurity LPA, and has the conversion rate close to 100%.
Drawings
FIG. 1 is a NMR spectrum of the untreated wild-type pfGDPD hydrolyzed lysophospholipid of example 1.
FIG. 2 is a NMR spectrum of hydrolyzed lysophospholipids after treatment with the wild-type pfGDPD metal ion chelator of example 2.
FIG. 3 is a mass spectrum of hydrolyzed lysophospholipid after treatment with the wild-type pfGDPD metal ion chelator of example 2.
Detailed Description
The following describes in detail specific embodiments of the present invention. It should be understood that the detailed description and specific examples, while indicating the present invention, are given by way of illustration and explanation only, not limitation.
Example 1: treated purified pfGDPD hydrolyzed lysophospholipids
(1) Metal ion chelator treatment of pfGDPD: EDTA-2Na was added to the purified pfGDPD at a final concentration of 20mM, and the mixture was allowed to stand at 4 ℃ for 2 hours.
(2) pfGDPD after EDTA-2Na treatment hydrolyzed lysophospholipids: lysophosphatidylcholine LPC (16:0) was dissolved in borate buffer (pH 8.0), and pfGDPD treated in step (1) was added and reacted at 30 ℃ for 4 hours at 300r/min in a constant temperature shaker.
The reaction product was subjected to NMR examination, and the results showed that (FIG. 2) wild-type pfGDPD treated with a metal ion chelating agent had a significantly enhanced ability to catalyze hydrolysis of lysophospholipid substrate, and that the reaction system contained only GPC, and no formation of LPA (16:0) or residue of LPC (16:0) was detected, and the purity of the formed diglyceride phosphate (GPC) was high.
Mass spectrometry of the reaction samples of this example showed (FIG. 3) that only GPC was detected, confirming 100% conversion to diglycerol phosphate (GPC) during the reaction.
Example 2
Determination of the formation of GPC by hydrolysis of lysophospholipids after treatment of pfGDPD with different Metal ion chelators: disodium ethylenediaminetetraacetate, nitrilotriacetic acid, diethylenetriaminepentaacetic acid and its sodium salt, citric acid and its sodium salt, tartaric acid and its sodium salt, gluconic acid and its sodium salt, each of which was added to the purified pfGDPD at a final concentration of 20mM, were allowed to stand at 4 ℃ for 2 hours, and then the thus-treated pfGDPD was taken out to hydrolyze lysophospholipids, respectively, and the reaction system and reaction conditions were the same as those in example 1. And (3) performing nuclear magnetic resonance detection on the reacted product, wherein results show that the treatment effects of different metal ion chelating agents are not obviously different, and the conversion rate of diglyceride phosphate (GPC) generated in the reaction process can reach 100%.
Comparative example: untreated purified pfGDPD hydrolyzed lysophospholipids
The raw material is lysophosphatidylcholine (16:0LPC)
Lysophosphatidylcholine LPC (16:0) was dissolved in borate buffer (pH 8.0), and purified pfGDPD was added and reacted at 30 ℃ for 4 hours at 300r/min in a constant temperature shaker. The reaction product was taken and subjected to NMR examination, and the results showed that (FIG. 1) untreated wild-type pfGDPD had poor ability to catalyze hydrolysis of lysophospholipid substrate, and that the reaction system contained not only GPC but also LPA and unreacted substrate LPC (16:0), and that the conversion rate to diglyceride phosphate GPC was within 5%.
Sequence listing
<110> university of southern China's science
<120> preparation method of high-purity diglyceride phosphate
<160> 2
<170> SIPOSequenceListing 1.0
<210> 2
<211> 253
<212> PRT
<213> Artificial Sequence (Artificial Sequence)
<400> 2
Met Val Gly Asn Pro Met Trp Glu Arg Asp Lys Ile Ile Val Leu Gly
1 5 10 15
His Arg Gly Tyr Met Ala Lys Tyr Pro Glu Asn Ser Leu Leu Ser Ile
20 25 30
Arg Lys Ala Ile Glu Ala Gly Ala Asp Gly Val Glu Ile Asp Val Trp
35 40 45
Leu Ser Lys Asp Asn Lys Val Ile Leu Met His Asp Glu Thr Ile Asp
50 55 60
Arg Thr Ser Asn Leu Lys Gly Arg Gln Lys Glu Met Thr Leu Glu Glu
65 70 75 80
Leu Lys Lys Ala Asn Ile Gly Met Gly Glu Arg Ile Pro Thr Leu Glu
85 90 95
Glu Val Phe Glu Ile Leu Pro Lys Asp Ala Leu Leu Asn Ile Glu Ile
100 105 110
Lys Asp Arg Asp Ala Ala Lys Glu Val Ala Arg Ile Val Ser Glu Asn
115 120 125
Asn Pro Glu Arg Val Met Ile Ser Ser Phe Asp Ile Glu Ala Leu Arg
130 135 140
Glu Tyr Arg Lys Tyr Asp Asp Thr Thr Ile Met Gly Leu Leu Val Asp
145 150 155 160
Lys Glu Glu Thr Val Pro Leu Ile Pro Lys Leu Lys Glu Lys Leu Asn
165 170 175
Leu Trp Ser Val Asn Val Pro Met Glu Ala Ile Pro Ile Ile Gly Phe
180 185 190
Glu Lys Thr Tyr Gln Ala Ile Lys Trp Val Arg Ser Leu Gly Leu Lys
195 200 205
Ile Val Leu Trp Thr Glu Asp Asp Lys Leu Phe Tyr Val Asp Glu Asn
210 215 220
Leu Lys Arg Leu Leu Gly Met Phe Glu Val Val Ile Ala Asn Asp Val
225 230 235 240
Glu Arg Met Val Ser Tyr Leu Ser Ser Leu Gly Ile Arg
245 250
<210> 2
<211> 759
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 2
atggtaggta acccaatgtg ggagcgtgat aagatcatcg tcctgggtca tcgtggttac 60
atggcaaagt acccggagaa cagcctgctg tctatccgta aagctattga agcaggtgca 120
gatggtgttg aaatcgatgt atggctgtct aaagacaaca aagtgatcct gatgcacgac 180
gaaaccatcg accgtacctc taacctgaaa ggccgtcaga aagaaatgac gctggaggaa 240
ctgaagaaag cgaacatcgg tatgggcgaa cgtatcccga ctctggaaga agtattcgaa 300
atcctgccga aagacgctct gctgaacatc gaaatcaaag accgtgacgc tgctaaagaa 360
gtcgcccgta ttgtctctga gaacaacccg gaacgtgtta tgatctcttc ctttgacatc 420
gaagcgctgc gtgaataccg caaatacgac gacactacta tcatgggtct gctggtagat 480
aaagaagaaa ccgtgccgct gatccctaaa ctgaaagaga aactgaacct gtggagcgtt 540
aacgtgccga tggaagcgat tccgattatt ggcttcgaga agacctacca agcgatcaaa 600
tgggtgcgca gcctgggcct gaagattgtt ctgtggaccg aagatgataa actgttctat 660
gtggatgaga atctgaaacg cctgctgggc atgttcgaag ttgttattgc caatgatgtt 720
gaacgcatgg tttcctatct gtcctccctg ggcattcgc 759

Claims (9)

1. A preparation method of high-purity diglyceride phosphate is characterized in that lysophospholipid is used as a raw material, pfGDPD treated by a metal ion chelating agent is used as a catalyst, and the lysophospholipid is hydrolyzed in an aqueous phase system to obtain a diglyceride phosphate product; the amino acid sequence of the pfGDPD is SEQ ID No. 1.
2. The process according to claim 1, wherein the high-purity diglyceride of glycerophosphate is prepared by dissolving lysophospholipid in a buffer solution having a pH of 8.0, and adding pfGDPD treated with a chelating agent to the reaction system at a temperature of 30 to 90 ℃ to conduct an enzymatic hydrolysis reaction.
3. The method according to claim 2, wherein the buffer solution is a boric acid buffer.
4. The method according to claim 1, wherein the lysophospholipid is one or more of lysophosphatidylcholine, lysophosphatidylethanolamine, lysophosphatidylserine, lysophosphatidylinositol, and lysophosphatidylglycerol.
5. The method according to claim 2, wherein the lysophospholipid is one or more of lysophosphatidylcholine, lysophosphatidylethanolamine, lysophosphatidylserine, lysophosphatidylinositol, and lysophosphatidylglycerol.
6. The method according to claim 1 or 2 or 3 or 4 or 5, wherein the treatment temperature of the metal ion chelating agent is 4-90 ℃, the treatment time is 1-12h, and the concentration of the chelating agent is 10-50 mM.
7. The process according to claim 6, wherein the chelating agent is one or more selected from the group consisting of ethylenediaminetetraacetic acid, disodium ethylenediaminetetraacetate, nitrilotriacetic acid, diethylenetriaminepentaacetic acid and salts thereof, citric acid and salts thereof, tartaric acid and salts thereof, and gluconic acid and salts thereof.
8. The preparation method of claim 6, wherein the conditions of the enzymolysis reaction are 30-50 ℃, 4-48 h, and 300 +/-200 r/min of stirring.
9. The preparation method of claim 7, wherein the conditions of the enzymolysis reaction are 30-50 ℃, 4-48 h, and 300 +/-200 r/min of stirring.
CN202110053622.0A 2021-01-15 2021-01-15 Preparation method of high-purity diglyceride phosphate Active CN112877377B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110053622.0A CN112877377B (en) 2021-01-15 2021-01-15 Preparation method of high-purity diglyceride phosphate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110053622.0A CN112877377B (en) 2021-01-15 2021-01-15 Preparation method of high-purity diglyceride phosphate

Publications (2)

Publication Number Publication Date
CN112877377A true CN112877377A (en) 2021-06-01
CN112877377B CN112877377B (en) 2023-02-14

Family

ID=76048020

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110053622.0A Active CN112877377B (en) 2021-01-15 2021-01-15 Preparation method of high-purity diglyceride phosphate

Country Status (1)

Country Link
CN (1) CN112877377B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112662644A (en) * 2021-01-19 2021-04-16 华南理工大学 Diglycerol phosphate phosphodiesterase mutant and application thereof
CN112662645A (en) * 2021-01-19 2021-04-16 华南理工大学 Sphingomyelinase D mutant and application thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2680196A1 (en) * 2007-03-08 2008-09-12 The New Zealand Institute For Plant And Food Research Limited Transferases, epimerases, polynucleotides encoding these and uses thereof
CN102277393A (en) * 2011-08-18 2011-12-14 河南工业大学 Method for preparing lysophosphatidyl choline by enzymatic alcoholysis
CN108118040A (en) * 2017-12-05 2018-06-05 南京农业大学 Soybean GDPD protein coding genes GmGDPD1 and its application
CN110564787A (en) * 2019-08-02 2019-12-13 大渔华创(广州)海洋生物科技有限公司 Polyunsaturated fatty acid-rich blood phospholipid composition and preparation method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2680196A1 (en) * 2007-03-08 2008-09-12 The New Zealand Institute For Plant And Food Research Limited Transferases, epimerases, polynucleotides encoding these and uses thereof
CN102277393A (en) * 2011-08-18 2011-12-14 河南工业大学 Method for preparing lysophosphatidyl choline by enzymatic alcoholysis
CN108118040A (en) * 2017-12-05 2018-06-05 南京农业大学 Soybean GDPD protein coding genes GmGDPD1 and its application
CN110564787A (en) * 2019-08-02 2019-12-13 大渔华创(广州)海洋生物科技有限公司 Polyunsaturated fatty acid-rich blood phospholipid composition and preparation method thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
FANGHUA WANG等: "Expression and Characterization of a Novel Glycerophosphodiester Phosphodiesterase from Pyrococcus furiosus DSM 3638 That Possesses Lysophospholipase D Activity", 《INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES》 *
李招等: "溶血磷脂的制备、分离、检测及应用研究进展", 《中国油脂》 *
赖林辉: "一种新型甘油磷酸二酯磷酸二酯酶的表达、纯化及酶学性质研究", 《中国优秀博硕士学位论文全文数据库(硕士) 工程科技Ⅰ辑》 *
闵雪珂: "pfGDPD水解溶血磷脂酰胆碱反应中甘油磷脂酰胆碱的形成机理初探", 《中国知网》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112662644A (en) * 2021-01-19 2021-04-16 华南理工大学 Diglycerol phosphate phosphodiesterase mutant and application thereof
CN112662645A (en) * 2021-01-19 2021-04-16 华南理工大学 Sphingomyelinase D mutant and application thereof
CN112662644B (en) * 2021-01-19 2022-04-22 华南理工大学 Diglycerol phosphate phosphodiesterase mutant and application thereof
CN112662645B (en) * 2021-01-19 2022-04-22 华南理工大学 Sphingomyelinase D mutant and application thereof

Also Published As

Publication number Publication date
CN112877377B (en) 2023-02-14

Similar Documents

Publication Publication Date Title
CN112877377B (en) Preparation method of high-purity diglyceride phosphate
Recsei et al. Pyruvoyl enzymes
ES2206099T3 (en) A PROCEDURE FOR THE PREPARATION OF FOSFATIDILSERINAS.
Augustinsson et al. Enzymatic hydrolysis of organophosphorus compounds
Ni et al. N-phosphoryl amino acid models for PN bonds in prebiotic chemical evolution
EP1890706B1 (en) Process for the preparation and isolation of phosphatides
Mikhailov et al. Hydrolysis of 2'-and 3'-C-methyluridine 2', 3'-cyclic monophosphates and interconversion and dephosphorylation of the resulting 2'-and 3'-monophosphates: comparison with the reactions of uridine monophosphates.
Damnjanović et al. Enzymatic modification of phospholipids by phospholipase D
US4659671A (en) Enzymatic separation of racemic mixtures of hydroxy compounds
WO2005045020A2 (en) Enzymatic synthesis, modification and decomposition of silicon(iv) compounds and other metal(iv) compounds
EP1739183A1 (en) Method of removing enzyme and method of base exchange or hydrolysis of phospholipid using the same
JPH0279990A (en) Production of phosphatidylserine
CN113215205A (en) Method for preparing hydroxy fatty acid
JP5526467B2 (en) Method for producing ceramide
JP2731852B2 (en) A new method for producing lysophosphatidylcholine.
Kosolapoff Preparation of a t-Alkyl Phosphite
JPH03123493A (en) Hydrolysis of diacylglyceroline lipid
US20040121427A1 (en) Soybean phosphopeptide calcium and method for producing thereof
KR100225669B1 (en) Process for preparing highly pure phospholipid using enzyme
Serysheva et al. GTPase activity of bacteriophage T4 sheath protein
JP2683590B2 (en) Method for producing enzyme-converted phospholipid
JPH0471906B2 (en)
Kersten et al. Hydroxylysine in wool
WO2019117187A1 (en) Method for preparing sodium cyclic phosphatidic acid
JPH0423995A (en) Transpeptidation reagent and method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant